4512.T

Aug 28, 2026, 01:27 UTC

Asset Value Investors, a London-based investment adviser, increased its shareholding in Wakamoto Pharmaceutical from 10.60% to 11.64%, as disclosed in a change report filed with the Kanto Finance Bureau on August 27, 2026.